MMP-9, which is upregulated in DR, cleaves Netrin-1 into a bioactive VI-V fragment that increases vascular permeability and diabetic macular edema, and inhibiting MMP-9 prevents this pathological permeability. Here, MMP9 is linked to diabetic macular edema.